| Financial Year |
March 31 2023 |
| Monetary Funds |
447,842,852.00 |
| Held-for-trading Financial Assets |
28,090,000.00 |
| Notes Receivable |
145,911,688.06 |
| Accounts Receivable |
419,509,122.28 |
| Advances to Suppliers |
12,824,856.14 |
| Other Receivables |
16,732,484.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
135,505,101.57 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
32,742,985.53 |
| Total Current Assets |
1,245,302,523.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
80,115,140.44 |
| Investment Properties |
-- |
| Fixed Assetes |
269,117,607.45 |
| Under-construction Projects |
229,233,099.44 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
22,182,898.99 |
| R&D expenses |
-- |
| Goodwill |
506,274.58 |
| Long-Term Deferred and Prepaid Expenses |
9,798,459.08 |
| Deferred Income Tax Assets |
19,101,489.16 |
| Other Non-Current Assets |
8,142,669.49 |
| Sub-Total of Non-Current Assets |
652,250,682.11 |
| Total Assets |
1,897,553,205.25 |
| Short-Term Loans |
30,131,350.94 |
| Trading Financial liabilities |
-- |
| Notes Payable |
174,848,965.43 |
| Accounts Payable |
248,972,578.06 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,275,307.12 |
| Taxes Payable |
5,042,335.05 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
18,035,641.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,899,680.38 |
| Other Current Liabilities |
361,276.55 |
| Sub-Total of Current Liabilities |
505,346,184.94 |
| Long-term Loans |
-- |
| Bonds Payable |
283,770,615.62 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
10,666,517.69 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
307,517,604.63 |
| Total Liabilities |
812,863,789.57 |
| Paid-In Capital(Or Share Stock) |
149,589,439.00 |
| Capital Surplus |
400,854,169.67 |
| Surplus Reserve |
37,896,129.90 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
435,658,439.60 |
| Minority Stockholder's Interest |
9,095,530.80 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,075,593,884.88 |
| Owner's Equity（Stockholder's Equity） |
1,084,689,415.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,897,553,205.25 |
